Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Drugs for Toxoplasmosis Market by Type (Injection, Tablet, Others), By Application (Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Drugs for Toxoplasmosis Market by Type (Injection, Tablet, Others), By Application (Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 139449 3300 Pharma & Healthcare 377 244 Pages 4.7 (49)
                                          

Toxoplasmosis is a parasitic disease caused by the Toxoplasma gondii. It can be transmitted to humans through contact with infected cat feces, eating undercooked meat, or drinking contaminated water. The infection can also be passed from mother to child during pregnancy. Symptoms of toxoplasmosis include fever, muscle aches, and swollen lymph nodes. In some cases it may cause eye inflammation and brain damage in infants born to mothers who are infected during pregnancy. The global drugs for toxoplasmosis market is expected to grow at a CAGR of 5% from 2021-2030 due to increasing prevalence of toxoplasmosis in developing countries such as India and China coupled with the rising awareness about the disease among people across the globe.

Some Of The Growth Factors Of This Market:

  1. The global Toxoplasmosis market is driven by factors such as increasing prevalence of toxoplasmosis, rising awareness about the disease and its treatment, and growing demand for immunoglobulin therapy in developing countries such as China and India.
  2. Increasing prevalence of toxoplasmosis is one of the major drivers for the growth of this market because it leads to increased incidence rates which in turn increases demand for drugs used to treat this infection. For instance. This number is expected to increase due to factors such as climate change and population growth which will lead to increased risk exposure (WHO).
  3. Rising awareness about the disease and its treatment also drives this market because it leads patients who have been diagnosed with toxoplasmosis or those who are at risk for contracting it (such as pregnant women) seek out treatments that can help them manage their condition or prevent them from getting infected in the first place (WHO). This number is expected to increase due to factors such as climate change and population growth which will lead to increased risk exposure (WHO).

Industry Growth Insights published a new data on “Drugs for Toxoplasmosis Market”. The research report is titled “Drugs for Toxoplasmosis Market research by Types (Injection, Tablet, Others), By Applications (Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Other), By Players/Companies Turing Pharmaceutical, Snowdon, Guangzhou Baiyunshan Pharmaceutical Co., Ltd., Taj Pharmaceuticals Limited, Glaxo Smithkline Pharmaceuticals Ltd., ...”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Drugs for Toxoplasmosis Market Research Report

By Type

Injection, Tablet, Others

By Application

Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Other

By Companies

Turing Pharmaceutical, Snowdon, Guangzhou Baiyunshan Pharmaceutical Co., Ltd., Taj Pharmaceuticals Limited, Glaxo Smithkline Pharmaceuticals Ltd., ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

244

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Drugs for Toxoplasmosis Industry Outlook


Global Drugs for Toxoplasmosis Market Report Segments:

The global Drugs for Toxoplasmosis market is segmented on the basis of:

Types

Injection, Tablet, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Turing Pharmaceutical
  2. Snowdon
  3. Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  4. Taj Pharmaceuticals Limited
  5. Glaxo Smithkline Pharmaceuticals Ltd.
  6. ...

Global Drugs for Toxoplasmosis Market Overview


Highlights of The Drugs for Toxoplasmosis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Injection
    2. Tablet
    3. Others
  1. By Application:

    1. Chronic Toxoplasmosis Treatment
    2. Acute Toxoplasmosis Treatment
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Drugs for Toxoplasmosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Drugs for Toxoplasmosis Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


There is no cure for toxoplasmosis, but there are many different drugs that can help treat the infection. Some of these drugs are prescribed by a doctor, while others can be purchased over the counter.

Some of the major players in the drugs for toxoplasmosis market are Turing Pharmaceutical, Snowdon, Guangzhou Baiyunshan Pharmaceutical Co., Ltd., Taj Pharmaceuticals Limited, Glaxo Smithkline Pharmaceuticals Ltd..

The drugs for toxoplasmosis market is expected to register a CAGR of 5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Drugs for Toxoplasmosis Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Drugs for Toxoplasmosis Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Drugs for Toxoplasmosis Market - Supply Chain
   4.5. Global Drugs for Toxoplasmosis Market Forecast
      4.5.1. Drugs for Toxoplasmosis Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Drugs for Toxoplasmosis Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Drugs for Toxoplasmosis Market Absolute $ Opportunity

5. Global Drugs for Toxoplasmosis Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      5.3.1. Injection
      5.3.2. Tablet
      5.3.3. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Drugs for Toxoplasmosis Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      6.3.1. Chronic Toxoplasmosis Treatment
      6.3.2. Acute Toxoplasmosis Treatment
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Drugs for Toxoplasmosis Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Drugs for Toxoplasmosis Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Drugs for Toxoplasmosis Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Drugs for Toxoplasmosis Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Drugs for Toxoplasmosis Demand Share Forecast, 2019-2029

9. North America Drugs for Toxoplasmosis Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Drugs for Toxoplasmosis Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      9.4.1. Chronic Toxoplasmosis Treatment
      9.4.2. Acute Toxoplasmosis Treatment
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      9.7.1. Injection
      9.7.2. Tablet
      9.7.3. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Drugs for Toxoplasmosis Demand Share Forecast, 2019-2029

10. Latin America Drugs for Toxoplasmosis Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Drugs for Toxoplasmosis Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      10.4.1. Chronic Toxoplasmosis Treatment
      10.4.2. Acute Toxoplasmosis Treatment
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      10.7.1. Injection
      10.7.2. Tablet
      10.7.3. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Drugs for Toxoplasmosis Demand Share Forecast, 2019-2029

11. Europe Drugs for Toxoplasmosis Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Drugs for Toxoplasmosis Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      11.4.1. Chronic Toxoplasmosis Treatment
      11.4.2. Acute Toxoplasmosis Treatment
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      11.7.1. Injection
      11.7.2. Tablet
      11.7.3. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Drugs for Toxoplasmosis Demand Share, 2019-2029

12. Asia Pacific Drugs for Toxoplasmosis Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Drugs for Toxoplasmosis Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      12.4.1. Chronic Toxoplasmosis Treatment
      12.4.2. Acute Toxoplasmosis Treatment
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      12.7.1. Injection
      12.7.2. Tablet
      12.7.3. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Drugs for Toxoplasmosis Demand Share, 2019-2029

13. Middle East & Africa Drugs for Toxoplasmosis Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Drugs for Toxoplasmosis Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Drugs for Toxoplasmosis Market Size and Volume Forecast by Application
      13.4.1. Chronic Toxoplasmosis Treatment
      13.4.2. Acute Toxoplasmosis Treatment
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Drugs for Toxoplasmosis Market Size and Volume Forecast by Type
      13.7.1. Injection
      13.7.2. Tablet
      13.7.3. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Drugs for Toxoplasmosis Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Drugs for Toxoplasmosis Market: Market Share Analysis
   14.2. Drugs for Toxoplasmosis Distributors and Customers
   14.3. Drugs for Toxoplasmosis Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Turing Pharmaceutical
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Snowdon
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Taj Pharmaceuticals Limited
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Glaxo Smithkline Pharmaceuticals Ltd.
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. ...
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us